BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moore RA, Beckthold B, Wong S, Kureishi A, Bryan LE. Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother. 1995;39:107-111. [PMID: 7695290 DOI: 10.1128/aac.39.1.107] [Cited by in Crossref: 119] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Revel-Viravau V, Truong QC, Moreau N, Jarlier V, Sougakoff W. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Antimicrob Agents Chemother 1996;40:2054-61. [PMID: 8878580 DOI: 10.1128/AAC.40.9.2054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol. 2009;47:3600-3607. [PMID: 19759218 DOI: 10.1128/jcm.00744-09] [Cited by in Crossref: 93] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
3 Nishizawa T, Suzuki H, Hibi T. Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. J Clin Biochem Nutr. 2009;44:119-124. [PMID: 19308265 DOI: 10.3164/jcbn.08-220r] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
4 Suzuki H, Nishizawa T, Muraoka H, Hibi T. Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation. Antimicrob Agents Chemother. 2009;53:1720-1721. [PMID: 19188389 DOI: 10.1128/aac.00049-09] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
5 Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Front Cell Infect Microbiol 2017;7:168. [PMID: 28529929 DOI: 10.3389/fcimb.2017.00168] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
6 Hakanen A, Jalava J, Kotilainen P, Jousimies-Somer H, Siitonen A, Huovinen P. gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother 2002;46:2644-7. [PMID: 12121947 DOI: 10.1128/AAC.46.8.2644-2647.2002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
7 Rimbara E, Noguchi N, Yamaguchi T, Narui K, Kawai T, Sasatsu M. Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr Microbiol. 2005;51:1-5. [PMID: 15971095 DOI: 10.1007/s00284-004-4488-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
8 Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM Jr, Camargo MC, Fox JG. Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations. J Clin Microbiol 2021;59:e03203-20. [PMID: 33692136 DOI: 10.1128/JCM.03203-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jones KR, Cha JH, Merrell DS. Who’s Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori. Curr Drug ther. 2008;3:190-203. [PMID: 21765819 DOI: 10.2174/157488508785747899] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
10 Ciccaglione AF, Cellini L, Grossi L, Marzio L. Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pyloriWorld J Gastroenterol 2012; 18(32): 4386-4390 [PMID: 22969203 DOI: 10.3748/wjg.v18.i32.4386] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
11 Zhang C, Cao M, Lv T, Wang H, Liu X, Xie Y, Lv N, Chen H, Cram DS, Zhong J, Zhou L. Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study. Eur J Clin Microbiol Infect Dis 2021;40:1599-608. [PMID: 33646449 DOI: 10.1007/s10096-021-04188-4] [Reference Citation Analysis]
12 Binh TT, Shiota S, Suzuki R, Matsuda M, Trang TT, Kwon DH, Iwatani S, Yamaoka Y. Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. J Antimicrob Chemother. 2014;69:1796-1803. [PMID: 24648504 DOI: 10.1093/jac/dku050] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
13 Yang JC, Lee PI, Hsueh PR. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. Eur J Clin Microbiol Infect Dis. 2010;29:1369-1375. [PMID: 20658256 DOI: 10.1007/s10096-010-1009-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
14 Bago P, Vcev A, Tomic M, Rozankovic M, Marusić M, Bago J. High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. Wien Klin Wochenschr 2007;119:372-8. [PMID: 17634896 DOI: 10.1007/s00508-007-0807-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
15 Mégraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 2004;53:1374-1384. [PMID: 15306603 DOI: 10.1136/gut.2003.022111] [Cited by in Crossref: 543] [Cited by in F6Publishing: 548] [Article Influence: 30.2] [Reference Citation Analysis]
16 Nishizawa T, Suzuki H, Kurabayashi K, Masaoka T, Muraoka H, Mori M, Iwasaki E, Kobayashi I, Hibi T. Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan. Antimicrob Agents Chemother. 2006;50:1538-1540. [PMID: 16569878 DOI: 10.1128/aac.50.4.1538-1540.2006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea. World J Gastroenterol 2014; 20(22): 6932-6938 [PMID: 24944485 DOI: 10.3748/wjg.v20.i22.6932] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
18 Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: Current status and future concepts. World J Gastroenterol 2014; 20(18): 5283-5293 [PMID: 24833858 DOI: 10.3748/wjg.v20.i18.5283] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
19 Kim JH, Cho EH, Kim KS, Kim HY, Kim YM. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates. Antimicrob Agents Chemother 1998;42:190-3. [PMID: 9449286 DOI: 10.1128/AAC.42.1.190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
20 Glocker E, Kist M. Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol. 2004;42:2241-2246. [PMID: 15131201 DOI: 10.1128/jcm.42.5.2241-2246.2004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
21 Nishizawa T, Suzuki H. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Front Mol Biosci. 2014;1:19. [PMID: 25988160 DOI: 10.3389/fmolb.2014.00019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
22 Gong RJ, Xu CX, Li H, Liu XM. Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis. World J Clin Cases 2021; 9(1): 133-147 [PMID: 33511178 DOI: 10.12998/wjcc.v9.i1.133] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Glocker E, Stueger HP, Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother. 2007;51:346-349. [PMID: 17043117 DOI: 10.1128/aac.00614-06] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
24 Nishizawa T, Suzuki H, Umezawa A, Muraoka H, Iwasaki E, Masaoka T, Kobayashi I, Hibi T. Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR. J Clin Microbiol. 2007;45:303-305. [PMID: 17122023 DOI: 10.1128/jcm.01997-06] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
25 Marais A, Mendz GL, Hazell SL, Mégraud F. Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 1999;63:642-74. [PMID: 10477311 DOI: 10.1128/MMBR.63.3.642-674.1999] [Cited by in Crossref: 142] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
26 Wang G, Wilson TJ, Jiang Q, Taylor DE. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori. Antimicrob Agents Chemother 2001;45:727-33. [PMID: 11181351 DOI: 10.1128/AAC.45.3.727-733.2001] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
27 Rhie SY, Park JY, Shin TS, Kim JW, Kim BJ, Kim JG. Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of Helicobacter pylori over a 14-Year Period: A Single Center Study in Korea. Antibiotics (Basel) 2020;9:E287. [PMID: 32471292 DOI: 10.3390/antibiotics9060287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Tshibangu-Kabamba E, Ngoma-Kisoko PJ, Tuan VP, Matsumoto T, Akada J, Kido Y, Tshimpi-Wola A, Tshiamala-Kashala P, Ahuka-Mundeke S, Ngoy DM, Disashi-Tumba G, Yamaoka Y. Next-Generation Sequencing of the Whole Bacterial Genome for Tracking Molecular Insight into the Broad-Spectrum Antimicrobial Resistance of Helicobacter pylori Clinical Isolates from the Democratic Republic of Congo. Microorganisms 2020;8:E887. [PMID: 32545318 DOI: 10.3390/microorganisms8060887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514-533. [PMID: 26694080 DOI: 10.1111/apt.13497] [Cited by in Crossref: 310] [Cited by in F6Publishing: 288] [Article Influence: 44.3] [Reference Citation Analysis]
30 Garcia M, Raymond J, Garnier M, Cremniter J, Burucoa C. Distribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in France. Antimicrob Agents Chemother. 2012;56:550-551. [PMID: 22064536 DOI: 10.1128/AAC.05243-11] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
31 An Y, Wang Y, Wu S, Wang YH, Qian X, Li Z, Fu YJ, Xie Y. Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis. World J Gastroenterol 2018; 24(29): 3302-3312 [PMID: 30090010 DOI: 10.3748/wjg.v24.i29.3302] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lin GY. Progress in research into the molecular mechanism of drug resistance of Helicobacter pyloriShijie Huaren Xiaohua Zazhi 2007; 15(25): 2698-2703 [DOI: 10.11569/wcjd.v15.i25.2698] [Reference Citation Analysis]
33 Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol 2021;18:613-29. [PMID: 34002081 DOI: 10.1038/s41575-021-00449-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang D, Gong YH, Yuan Y. Bacterial factors associated with Helicobacter pylori antibiotic resistance. Shijie Huaren Xiaohua Zazhi 2016; 24(29): 4102-4109 [DOI: 10.11569/wcjd.v24.i29.4102] [Reference Citation Analysis]
35 Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol 2013; 19(45): 8168-8180 [PMID: 24363506 DOI: 10.3748/wjg.v19.i45.8168] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
36 Sierra JM, Martinez-Martinez L, Vázquez F, Giralt E, Vila J. Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob Agents Chemother 2005;49:1714-9. [PMID: 15855486 DOI: 10.1128/AAC.49.5.1714-1719.2005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
37 Taylor DE, Chau AS. Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates. Antimicrob Agents Chemother 1997;41:665-71. [PMID: 9056011 DOI: 10.1128/AAC.41.3.665] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
38 Eng NF, Ybazeta G, Chapman K, Fraleigh NL, Letto R, Altman E, Diaz-Mitoma F. Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario. Can J Infect Dis Med Microbiol 2015;26:137-44. [PMID: 26236355 DOI: 10.1155/2015/853287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Mégraud F. Basis for the management of drug-resistant Helicobacter pylori infection. Drugs. 2004;64:1893-1904. [PMID: 15329036 DOI: 10.2165/00003495-200464170-00003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
40 Musso D, Drancourt M, Osscini S, Raoult D. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii. Antimicrob Agents Chemother 1996;40:870-3. [PMID: 8849242 DOI: 10.1128/AAC.40.4.870] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y. Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother. 2015;59:2343-2348. [PMID: 25645832 DOI: 10.1128/aac.04852-14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
42 Wilson DL, Abner SR, Newman TC, Mansfield LS, Linz JE. Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay. J Clin Microbiol 2000;38:3971-8. [PMID: 11060054 DOI: 10.1128/JCM.38.11.3971-3978.2000] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
43 Marcus EA, Sachs G, Scott DR. Eradication of Helicobacter pylori Infection. Curr Gastroenterol Rep 2016;18:33. [PMID: 27177639 DOI: 10.1007/s11894-016-0509-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
44 Saracino IM, Pavoni M, Zullo A, Fiorini G, Lazzarotto T, Borghi C, Vaira D. Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review. Antibiotics (Basel) 2021;10:437. [PMID: 33919811 DOI: 10.3390/antibiotics10040437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Sanches BS, Martins GM, Lima K, Cota B, Moretzsohn LD, Ribeiro LT, Breyer HP, Maguilnik I, Maia AB, Rezende-Filho J, Meira AC, Pinto H, Alves E, Mascarenhas R, Passos R, de Souza JD, Trindade OR, Coelho LG. Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. World J Gastroenterol 2016; 22(33): 7587-7594 [PMID: 27672279 DOI: 10.3748/wjg.v22.i33.7587] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
46 Dorer MS, Fero J, Salama NR. DNA damage triggers genetic exchange in Helicobacter pylori. PLoS Pathog 2010;6:e1001026. [PMID: 20686662 DOI: 10.1371/journal.ppat.1001026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
47 Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T. Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens. United European Gastroenterol J. 2018;6:391-397. [PMID: 29774152 DOI: 10.1177/2050640617737215] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
48 Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003;47:3942-3944. [PMID: 14638505 DOI: 10.1128/aac.47.12.3942-3944.2003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
49 Yamamoto T, Takano T, Higuchi W, Nishiyama A, Taneike I, Yoshida K, Kanda H, Imamura Y. Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development. Antimicrob Agents Chemother 2011;55:4261-6. [PMID: 21730117 DOI: 10.1128/AAC.01105-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
50 Liou JM, Chang CY, Sheng WH, Wang YC, Chen MJ, Lee YC, Hung HW, Chian H, Chang SC, Wu MS, Lin JT. Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrob Agents Chemother. 2011;55:1123-1129. [PMID: 21189342 DOI: 10.1128/aac.01131-10] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
51 He H, Wang HM, Chi J. Detection of the drug-resistant gene of Helicobacter pyloriShijie Huaren Xiaohua Zazhi 2008; 16(5): 510-516 [DOI: 10.11569/wcjd.v16.i5.510] [Reference Citation Analysis]
52 Bińkowska A, Biernat MM, Łaczmański Ł, Gościniak G. Molecular Patterns of Resistance Among Helicobacter pylori Strains in South-Western Poland. Front Microbiol 2018;9:3154. [PMID: 30619218 DOI: 10.3389/fmicb.2018.03154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
53 Angol DC, Ocama P, Ayazika Kirabo T, Okeng A, Najjingo I, Bwanga F. Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. Biomed Res Int. 2017;2017:5430723. [PMID: 28555193 DOI: 10.1155/2017/5430723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
54 Oppegaard H, Sørum H. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish pathogen Aeromonas salmonicida. Antimicrob Agents Chemother 1996;40:1126-33. [PMID: 8723452 DOI: 10.1128/AAC.40.5.1126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
55 Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 2011;8:79-88. [DOI: 10.1038/nrgastro.2010.210] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 11.1] [Reference Citation Analysis]
56 Tanih NF, Ndip RN. Molecular Detection of Antibiotic Resistance in South African Isolates of Helicobacter pylori. Gastroenterol Res Pract. 2013;2013:259457. [PMID: 23710166 DOI: 10.1155/2013/259457] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
57 Mégraud F. Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. Gut Microbes. 2013;4:541-548. [PMID: 23929066 DOI: 10.4161/gmic.25930] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]